LifeStance director awarded 35,492 RSUs
LifeStance Health Group, Inc. director Lori Goltermann reported an equity compensation award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LifeStance Health Group, Inc. director Lori Goltermann reported an equity compensation award. On July 2, 2026, she acquired 35,492 shares of common stock at $0.00 per share through a grant classified as restricted stock units (RSUs). Following this award, she directly holds 35,492 shares, all represented by RSUs, each of which entitles her to receive one share of LifeStance common stock if vesting conditions are met.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 35,492 | $0.00 | $0.00 |
Footnotes (1)
- F1. Includes 35,492 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Key Figures
Key Terms
restricted stock units financial
RSUs financial
grant/award acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did LifeStance (LFST) report for Lori Goltermann?
Was Lori Goltermann’s LifeStance (LFST) award a market purchase or a compensation grant?
What does each restricted stock unit (RSU) for LifeStance (LFST) represent?
Is this LifeStance (LFST) Form 4 transaction a buy or sell signal?
AI-generated analysis. How Rhea-AI works. Not financial advice.